Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SNAP Trial: Different Schedules of Nab-Paclitaxel in Metastatic Breast Cancer
NCT01746225Phase 2Completed
- Sponsor
- ETOP IBCSG Partners Foundation
- Start
- Apr 2013
- Primary completion
- May 2016
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 6
01
Overview
Phase 2, randomised, open-label trial of paclitaxel in breast cancer (3 arms), sponsored by ETOP IBCSG Partners Foundation. Primary endpoint: Progression-free Survival at 18.2 months. Started Apr 2013; status: completed.
02
Drugs
paclitaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01746225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01746225.